Feedback / Questions
emactuzumab (RG7155) - SynOx Therap
https://www.prnewswire.com/news-releases/synox-therapeutics-secures-up-to-35m-debt-financing-with-hercules-capital-to-progress-development-and-commercialisation-of-emactuzumab-302130420.html
Apr 30, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next